Comparative Effectiveness of All-Oral Ixazomib-lenalidomide-dexamethasone (IRd) Following Bortezomib (V)-based Induction Versus Continued V-based Therapy in Patients with Newly Diagnosed Multiple Myeloma (NDMM)
AMERICAN JOURNAL OF HEMATOLOGY（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要